Research in the Pathogenesis of Hematologic Disorders

这是纽约大学多学科血液学培训项目的续签申请 已经存在了42年以上的医学院。该计划旨在提供两个- 在13名导师的指导下，为5-6名博士后研究员提供一年的研究机会。这个 培训教师由学术血液学家和血液病理学家组成，并积极申请实验室 血液病研究的基础科学方法与基础科学导师 纽约大学医学院院系。内部教职员工之间存在着丰富的互动 该计划以及与该机构的其他科学家的合作。该机构的临床研究已经 被美国国立卫生研究院认定为综合性癌症中心和艾滋病中心。这个 项目主管的研究涵盖了这两个领域。新的教员加强了基础科学 该计划的定位。学院在这个框架下工作，为未来的工作培养内科科学家。 在学术界。所有这些项目的一个共同主题是它们对人类疾病的定位。 这些目标将通过培训有前途的候选人在设计、执行和评估 实验，以便他们可以在基础和翻译方面加入学术内科科学家的行列 血液学研究。 相关性(请参阅说明)： 随着国家人口老龄化，我们更有必要对医学科学家进行培训 基础研究和转译研究中的血液病。纽约大学医学院的培训计划 将继续执行这项任务。

This is a renewal application for a multidisciplinary hematology training program at New York University School of Medicine which has been in existence for over 42 years. The program is designed to provide two- year research opportunities for 5-6 post-doctoral fellows under the guidance of a faculty of 13 mentors. The training faculty consists of academic hematologists and hematopathologists with active laboratories applying basic science methods to the study of hematologic disorders as well as mentors of the basic science departments of NYU School of Medicine. There is abundant interaction among the faculty members within the program as well as with other scientists at this institution. The clinical research at this institution has been recognized by the NIH in its designation as a Comprehensive Cancer Center and an AIDS Center. The program director's research spans both areas. New faculty members have strengthened the basic science orientation of the program. The faculty works with this framework to train physician-scientists for future work in the academic community. A common theme of all the projects is their orientation to human disease. These aims will be accomplished by training promising candidates in the design, execution and evaluation of experiments so that they may join the ranks of academic physician-scientists in basic as well as translational hematology research. RELEVANCE (See instructions): As the Nation's population is aging, it is becomes even more necessary that we train physician-scientists in hematologic disorders in basic and translational research. The training program at NYU School of Medicine will continue that mission.